Adjunct Principal Investigator Positions at LBI-RUD and CeMM, Vienna, Austria

CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences and LBI-RUD, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases have identical principles of excellence, competitiveness, internationality as well as mentoring and training, and both operate in a unique mode of super-cooperation, connecting biology with medicine, experiments with computation, discovery with translation, and science with society. We are partner institutes and located in the very same research building in the middle of the Vienna medical campus. Both have a partnership with the Medical University of Vienna and several faculty members have dual affiliations.

To complement and strengthen the current Faculty, CeMM and LBI-RUD are offering Adjunct Principal Investigator positions to highly professional individuals who work on an exciting problem of molecular medicine, preferably but not exclusively pertaining to Rare and Undiagnosed Diseases, Molecular Pharmacology, Immunity, Infection Biology, Inflammation, Neurologic Diseases, Hematopoiesis, Hematological Malignancies, Genome Integrity, Blood, Vascular Disorders or Metabolic Disorders.

Whom we are looking for:

We are looking for MD and/or PhD scientists either at their first independent appointment or already at the consolidation stage to apply their expertise close to a clinical setting in a stimulating research environment. Required are scientific quality and originality, a track record of achievements as well as a collaborative and interdisciplinary mindset.

What we offer:

We offer a collaboration/affiliation contract for initially 5 years including a PhD student position, and some consumables and facility service funds. The unique opportunity to become part of the CeMM/LBI-RUD Faculty. Benefit from lively scientific exchange, extend your network, collaborate and explore new possibilities – in science and beyond.

If you have the necessary drive and passion to make a difference, apply now for one of several positions of ADJUNCT PRINCIPAL INVESTIGATORS at LBI-RUD/CeMM. 

For more information, please visit https://cemm.at/career/open-positions/

Download PDF: https://cemm.at/fileadmin/img/Career/Adjunct_PI_Search_CeMM_LBI-RUD_2018.pdf 

Application Deadline: July 31, 2018

CeMM and LBI-RUD are equal opportunity employers, and the institutes have a strong intellectual environment that stems from the international nature of its employees. We believe that diversity and different cultural backgrounds are a clear advantage to successful research, collaborations, and the day-to-day business.

The mission of CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences is to achieve maximum scientific innovation in molecular medicine to improve healthcare. At CeMM, an international and creative team of scientists and medical doctors pursues free-minded basic life science research in a large and vibrant hospital environment of outstanding medical tradition and practice. CeMM’s research is based on post-genomic technologies and focuses on societally important diseases, such as immune disorders and infections, cancer and metabolic disorders. The goal of CeMM is to pioneer the science that nurtures the precise, personalized, predictive and preventive medicine of the future. CeMM is part of EU-LIFE an alliance of 13 top research centers in life sciences to support and strengthen European research excellence. Giulio Superti-Furga is Scientific Director of CeMM since 2005.

The research focus of LBI-RUD, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases is on rare diseases of the immune system, hematopoiesis, and the nervous system, which all together account for more than 50% of all rare diseases. LBI-RUD research will not only be relevant to the affected individuals and will provide the basis for targeted therapies, but will also provide unique and novel insights into human biology far beyond the specific disease, which will add to our understanding of much more frequent diseases. LBI-RUD is highly connected in global networks to promote cooperation and synergy between different disciplines and to engage rare disease patients, and LBI-RUD also holds close ties with its partner institutions, CeMM, the Medical University of Vienna, and the Children’s Cancer Research Institute (CCRI) of the St. Anna Children's Hospital. Kaan Boztug is Director of LBI-RUD since 2016.